CytoSorbents Appoints Dr. Rainer Kosanke as European Director of Scientific Affairs
July 08, 2013 09:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., July 8, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company commercializing its European Union approved CytoSorb® blood filter...
CytoSorbents Announces Start of $1M US Army Phase II SBIR Contract and Closing of Additional Funding
June 27, 2013 09:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., June 27, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB: CTSO), a critical care focused
company commercializing its European Union approved CytoSorb®...
CytoSorbents Announces FDA Approved US Air Force Funded Human Trauma Pilot Study for Rhabdomyolysis
June 17, 2013 08:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., June 17, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company using blood purification to treat life-threatening illnesses in the...
CytoSorbents Enters Into Exclusive Distribution Agreement for CytoSorb(R) With Hitit Medical Systems in Turkey
June 13, 2013 09:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., June 13, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused therapeutic device company using blood purification to treat life-threatening...
CytoSorbents Reports 2013 First Quarter Financial Results
May 16, 2013 07:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., May 16, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO) is a critical care focused company using blood purification to treat life-threatening illnesses in the...
Kathleen P. Bloch Appointed as Chief Financial Officer of CytoSorbents
May 13, 2013 08:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., May 13, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused therapeutic device company using blood purification to treat life-threatening...
CytoSorbents Enters Into Exclusive Distribution Agreement for CytoSorb(R) With L.IN.C. Medical Systems in the United Kingdom and Ireland
May 06, 2013 08:01 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., May 6, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused therapeutic device company using blood purification to treat life-threatening...
CytoSorbents CEO Provides Exclusive Interview With medGadget
May 01, 2013 09:30 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., May 1, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care-focused company using blood purification to treat life-threatening illnesses, announced...
CytoSorbents Appoints Christopher Cramer as Vice President of Business Development
April 15, 2013 08:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., April 15, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care-focused company using blood purification to treat life-threatening illnesses in the...
CytoSorbents Awarded Additional Phase I Option on US Army SBIR Trauma Contract
April 11, 2013 09:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., April 11, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused therapeutic device company using blood purification to treat life-threatening...